SC 13G: Adlai Nortye Ltd.

Ticker: ANL · Form: SC 13G · Filed: Mar 4, 2024 · CIK: 1944552

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by Adlai Nortye Ltd..

Risk Assessment

Risk Level: low

Filing Stats: 2,026 words · 8 min read · ~7 pages · Grade level 8.8 · Accepted 2024-03-04 16:02:34

Key Financial Figures

Filing Documents

IF THIS STATEMENT IS FILED PURSUANT

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: Not applicable.

OWNERSHIP

ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: See Item 9 of each cover page. (b) Percent of class: See Item 11 of each cover page. The calculation is based on a total of 110,700,805 ordinary shares of the Issuer outstanding as of December 31, 2023. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: See Item 5 of each cover page. (ii) Shared power to vote or to direct the vote: See Item 6 of each cover page. (iii) Sole power to dispose or to direct the disposition of: See Item 7 of each cover page. (iv) Shared power to dispose or to direct the disposition of: See Item 8 of each cover page. JIN YIN (BVI) LIMITED is the direct holder of the securities covered by this statement. JIN YIN (BVI) LIMITED is wolly owned by Shanghai Gaopei Duwei Biotechnology Co., Ltd.. Shanghai Gaopei Duwei Biotechnology Co., Ltd. holds 100.0% equity interest of JIN YIN (BVI) LIMITED. Hangzhou Jingyin Investment Partnership (Limited Partnership) holds 99.0% equity interest of Shanghai Gaopei Duwei Biotechnology Co., Ltd. Hangzhou Jingfeng Investment Management Company is the general partner of Hangzhou Jingyin Investment Partnership (Limited Partnership), and may be deemed to beneficially own the ordinary shares beneficially owned by Hangzhou Jingyin Investment Partnership (Limited Partnership). Shijun Feng holds 100.0% equity interest of Hangzhou Jingfeng Investment Management Company. Accoridngly, Shijun Feng may be deemed as the beneficial owner of the ordinary shares of the Issuer held by JIN YIN (BVI) LIMITED.

OWNERSHIP OF FIVE PERCENT OR LESS OF

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable.

OWNERSHIP OF MORE THAN FIVE PERCENT

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable.

IDENTIFICATION AND CLASSIFICATION OF

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable.

IDENTIFICATION AND CLASSIFICATION OF

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable.

NOTICE OF DISSOLUTION OF GROUP

ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable.

CERTIFICATIONS

ITEM 10. CERTIFICATIONS. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. LIST OF EXHIBITS Exhibit No. 99.1 Joint Filing Agreement SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: March 4, 2024 JIN YIN (BVI) LIMITED By: /s/ Shijun Feng Name: Shijun Feng Title: Director Shanghai Gaopei Duwei Biotechnology Co., Ltd. By: /s/ Shijun Feng Name: Shijun Feng Title: Director Hangzhou Jingyin Investment Partnership (Limited Partnership) By: Hangzhou Jingfeng Investment Management Company General Partner By: /s/ Yue’ai Jiang Name: Yue’ai Jiang Title: Authorized Person Hangzhou Jingfeng Investment Management Company By: /s/ Shijun Feng Name: Shijun Feng Title: Director Shijun Feng By: /s/ Shijun Feng Name: Shijun Feng

View Full Filing

View this SC 13G filing on SEC EDGAR

View on Read The Filing